The PARIS Test prescreens a broad panel of cancer drugs in patient-derived live tumor cells and provides actionable results 70% of the time, on average.
A cybersecurity expert weighs in on the recent Facebook outage, and how medical device companies (and others) can avoid the same mistake.
To realize the full potential of artificial intelligence and machine learning, data quality and security as well as regulatory changes are needed.
An extension of the in-mold decorating process, in-mold electronics’ initial applications will be in consumer goods and automotive interiors.
Improved properties may come at a reduced cost.
New microneedle technology can provide greater vaccine protection than a typical shot and is less painful.